kabutan

3-D Matrix,Ltd.(7777) Summary

7777
TSE Growth
3-D Matrix,Ltd.
333
JPY
-9
(-2.63%)
Dec 5, 11:30 am JST
2.14
USD
Dec 4, 9:30 pm EST
Result
PTS
outside of trading hours
334.9
Dec 5, 11:29 am JST
Summary Chart Historical News Financial Result
PER
133.2
PBR
18.1
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
345 JPY 2.22 USD
Previous Close Dec 4
342 JPY 2.20 USD
High Dec 5, 9:00 am
345 JPY 2.22 USD
Low Dec 5, 10:22 am
333 JPY 2.14 USD
Volume
893,600
Trading Value
0.30B JPY 1.95M USD
VWAP
337.54 JPY 2.18 USD
Minimum Trading Value
33,300 JPY 214 USD
Market Cap
0.04T JPY 0.26B USD
Number of Trades
501
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
High
1-Year Average
1,169
1-Year High Sep 16, 2025
16,543
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 2,000 11,774,300 5887.15
Nov 21, 2025 0 12,300,000
Nov 14, 2025 0 12,473,800
Nov 7, 2025 0 13,046,800
Oct 31, 2025 0 12,361,200
Company Profile
3-D Matrix, Ltd. is a bioventure company that develops medical products by applying peptide technology. The company operates both domestically and internationally.
Sector
Precision Instruments
3-D Matrix, Ltd. conducts research and development, manufacturing, and sales of medical devices and pharmaceuticals based on self-assembling peptide technology, for which it has obtained an exclusive license from MIT. The company's main development pipeline includes absorbable local hemostatic agents for surgical applications, mucosal lifting agents, post-bleeding prevention materials, adhesion prevention materials, wound healing materials for tissue regeneration, alveolar bone reconstruction materials, and drug delivery systems (DDS) for nucleic acid therapeutics. 3-D Matrix has established direct sales systems in the United States, Japan, and Australia, while also conducting sales through partner companies in some regions.